Gain expert insights on when to use therapeutic drug monitoring proactively to improve the efficacy of biologic therapy for inflammatory bowel disease (IBD) and reactively to guide decision-making following primary nonresponse or secondary loss of response to a biologic.
Keep Reading
Add A Comment